Validating a targeted next-generation sequencing assay and profiling somatic variants in Chinese non-small cell lung cancer patients

Hua Bai, Meina Wu, Lu Yang, Zhigang Wei, Xiaosheng Ding, Jinglin Yu, Yuyan Wang, Jianchun Duan, Zhijie Wang, Jie Wang, PIK3CA mutation in Chinese patients with lung squamous cell carcinoma. Chinese Journal of Cancer Research. ,vol. 25, pp. 416- 422 ,(2013) , 10.3978/J.ISSN.1000-9604.2013.08.03

T Soussi, K G Wiman, TP53: an oncogene in disguise Cell Death & Differentiation. ,vol. 22, pp. 1239- 1249 ,(2015) , 10.1038/CDD.2015.53

Tetsuya Mitsudomi, Yasushi Yatabe, Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer FEBS Journal. ,vol. 277, pp. 301- 308 ,(2010) , 10.1111/J.1742-4658.2009.07448.X

Jae Ro, Marivonne Rodriguez, Waun Ki Hong, Li Mao, Diane Liu, Jennifer E. Tseng, Gender differences in p53 mutational status in small cell lung cancer. Cancer Research. ,vol. 59, pp. 5666- 5670 ,(1999)

Yinling Zhuo, Qisen Guo, Pingping Song, Qiong Zhang, Chen Guo, Hongsheng Zeng, Yan Guan, Xiuju Liu, Chenqing Zhao, Correlation study and significance of the EGFR expression in serum, lymph nodes and tumor tissue of NSCLC. Thoracic Cancer. ,vol. 5, pp. 31- 37 ,(2014) , 10.1111/1759-7714.12048

Edward S Kim, Roy S Herbst, Ignacio I Wistuba, J Jack Lee, George R Blumenschein Jr, Anne Tsao, David J Stewart, Marshall E Hicks, Jeremy Erasmus Jr, Sanjay Gupta, Christine M Alden, Suyu Liu, Ximing Tang, Fadlo R Khuri, Hai T Tran, Bruce E Johnson, John V Heymach, Li Mao, Frank Fossella, Merrill S Kies, Vassiliki Papadimitrakopoulou, Suzanne E Davis, Scott M Lippman, Waun K Hong, None, The BATTLE Trial: Personalizing Therapy for Lung Cancer Cancer Discovery. ,vol. 1, pp. 44- 53 ,(2011) , 10.1158/2159-8274.CD-10-0010

B Karakas, K E Bachman, B H Park, Mutation of the PIK3CA oncogene in human cancers. British Journal of Cancer. ,vol. 94, pp. 455- 459 ,(2006) , 10.1038/SJ.BJC.6602970

Neal I. Lindeman, Philip T. Cagle, Mary Beth Beasley, Dhananjay Arun Chitale, Sanja Dacic, Giuseppe Giaccone, Robert Brian Jenkins, David J. Kwiatkowski, Juan-Sebastian Saldivar, Jeremy Squire, Erik Thunnissen, Marc Ladanyi, Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology Journal of Thoracic Oncology. ,vol. 8, pp. 823- 859 ,(2013) , 10.1097/JTO.0B013E318290868F

Jeffrey A Engelman, Liang Chen, Xiaohong Tan, Katherine Crosby, Alexander R Guimaraes, Rabi Upadhyay, Michel Maira, Kate McNamara, Samanthi A Perera, Youngchul Song, Lucian R Chirieac, Ramneet Kaur, Angela Lightbown, Jessica Simendinger, Timothy Li, Robert F Padera, Carlos García-Echeverría, Ralph Weissleder, Umar Mahmood, Lewis C Cantley, Kwok-Kin Wong, Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers Nature Medicine. ,vol. 14, pp. 1351- 1356 ,(2008) , 10.1038/NM.1890

Osamu Kawano, Hidefumi Sasaki, Katsuhiko Endo, Eriko Suzuki, Hiroshi Haneda, Haruhiro Yukiue, Yoshihiro Kobayashi, Motoki Yano, Yoshitaka Fujii, PIK3CA mutation status in Japanese lung cancer patients. Lung Cancer. ,vol. 54, pp. 209- 215 ,(2006) , 10.1016/J.LUNGCAN.2006.07.006